Katie Capps on integrating pharmacogenomic testing into the CMM process
DEC 10, 2020
Description Community
About

Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process. 

Comments